Syndax Announces PDUFA Action Date Extension for Revumenib NDA for Relapsed or Refractory KMT2Ar Acute Leukemia
– New PDUFA action date of December 26, 2024 allows FDA additional time to complete their review – WALTHAM, Mass., July...
PR News
SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine
David Arnon held senior leadership and CEO roles within the healthcare insurance industry at Harel Insurance and Clal Insurance, two...
SIGMA LITHIUM SIGNS INAUGURAL DEFERRED US$ 22.4 MILLION LETTER OF CREDIT EXPORT FINANCING WITH BANCO DO BRASIL
HIGHLIGHTS SÃO PAULO, Brazil, July 29, 2024 /PRNewswire/ -- Sigma Lithium Corporation ("Sigma Lithium" or the "Company") (NASDAQ: SGML, BVMF:...
Socket Mobile Launches XtremeScan XG640, a Rugged BYOD Scanner for Transportation & Logistics
FREMONT, Calif., July 29, 2024 /PRNewswire/ -- Socket Mobile (NASDAQ: SCKT), a leading provider of data capture and delivery solutions...
GSK and Flagship Pioneering partner to discover novel medicines and vaccines
LONDON and CAMBRIDGE, Mass., July 29, 2024 /PRNewswire/ -- GSK plc (LSE/NYSE: GSK) and Flagship Pioneering (Flagship), the bioplatform innovation...
Provident Financial Holdings Reports Fourth Quarter and Fiscal Year 2024 Results
Net Income of $1.95 Million in the June 2024 QuarterNet Interest Margin of 2.74% in the June 2024 Quarter Read...
GSK and Flagship Pioneering partner to discover novel medicines and vaccines
LONDON and CAMBRIDGE, Mass., July 29, 2024 /PRNewswire/ -- GSK plc (LSE/NYSE: GSK) and Flagship Pioneering (Flagship), the bioplatform innovation...
Organigram Announces Appointment of Craig Harris to Board of Directors
Contacts For Media enquiries: Megan McCrae Senior Vice President of Global Brands and Corporate Affairs megan.mccrae@organigram.ca For Investor Relations enquiries:...
Ocugen to Host Conference Call on Thursday, August 8 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2024 Financial Results
MALVERN, Pa., July 29, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused...
NUTEX HEALTH REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE
HOUSTON, July 29, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare...
GSK and Flagship Pioneering partner to discover novel medicines and vaccines
LONDON and CAMBRIDGE, Mass., July 29, 2024 /PRNewswire/ -- GSK plc (LSE/NYSE: GSK) and Flagship Pioneering (Flagship), the bioplatform innovation...
Marin Software Announces Estimated Preliminary Second Quarter 2024 Financial Results
Contacts Investor Relations, Marin Software ir@marinsoftware.com Media Contact Wesley MacLaggan Marketing, Marin Software (415) 399-2580 press@marinsoftware.com Marin Software Incorporated (NASDAQ:...
MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer
Contacts For Media: media@mindmed.co For Investors: ir@mindmed.co Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical...
LuxUrban Hotels Announces Agreement in Principle to Issue Up to $5.0 Million Senior Notes Due 2027
MIAMI, July 29, 2024 (GLOBE NEWSWIRE) -- LuxUrban Hotels Inc. (“LuxUrban” or the “Company”) (Nasdaq: LUXH), which secures long-term operating...
Manhattan Bridge Capital, Inc. Declares Quarterly Dividend
GREAT NECK, N.Y., July 29, 2024 (GLOBE NEWSWIRE) -- Manhattan Bridge Capital, Inc. (NASDAQ: LOAN) announced today that its board...
Linde Publishes 2023 Sustainable Development Report
WOKING, UNITED KINGDOM / ACCESSWIRE / July 29, 2024 / Linde (Nasdaq:LIN) announced today it has published its 2023 Sustainable...
Graphite One and Lucid Supply Agreement Announced at U.S. Capitol Briefing
Graphite One-Lucid agreement marks the first step in a 100% U.S.-based supply chain linking Alaska, Ohio and Arizona VANCOUVER, BC,...
IDEAYA Biosciences to Participate in Upcoming August 2024 Investor Relations Event
SOUTH SAN FRANCISCO, Calif., July 29, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed...
Integra LifeSciences Reports Second Quarter 2024 Financial Results
PRINCETON, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company,...
G-III Apparel Group, Ltd. Announces Increased Investment in AWWG
- Partnership Accelerates the International Expansion of G-III’s Owned Brands - Contacts G-III Apparel Group, Ltd. Company Contact: Priya Trivedi...
Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening
Shield is first blood test approved by FDA as a primary screening option for colorectal cancer and that meets performance...
GSK and Flagship Pioneering partner to discover novel medicines and vaccines
LONDON and CAMBRIDGE, Mass., July 29, 2024 /PRNewswire/ -- GSK plc (LSE/NYSE: GSK) and Flagship Pioneering (Flagship), the bioplatform innovation...
Elbit Systems Awarded Approximately $190 Million Contract to Supply Iron Sting Guided Mortar Munition to the Israeli Ministry of Defense
HAIFA, Israel, July 29, 2024 /PRNewswire/ -- Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems" or the "Company") announced...
Enlight Announces Financial Close on Atrisco Energy Storage Project
The financing package for the energy storage portion of the project includes over $400 million of loans and tax equity...
Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection
IRVINE, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that it has enrolled the...
First Batch of EHang’s EH216-S Delivered to Xishan Tourism and Completed Debut Passenger-Carrying Flights in Taiyuan
GUANGZHOU, China, July 29, 2024 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading...
ECARX Announces Board Change
SHANGHAI, July 29, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech...
KRISPY KREME® Encourages Fans to ‘Go for the Glaze’ During Games with $1 Doughnuts Beginning July 31
Brand also introduces Go USA Collection perfect for cheering on athletes Contacts Liv Weller Liv.Weller@fleishman.com Krispy Kreme® is encouraging Americans...
DBV Technologies présente ses résultats financiers du premier semestre 2024 et fait le point sur l’évolution de ses activités
Châtillon, France, 29 juillet (07:30 CEST), 2024DBV Technologies présente ses résultats financiers du premier semestre 2024 et fait le point...
Cognizant secures deal as Hays global technology partner, ushering in a new era of digital transformation and innovation
As Hays' global tech partner, Cognizant will use new innovative technologies to enhance customer experience and IT efficiency, in order...
Cepton Signs Definitive Agreement to be Acquired by Koito
After closing of the proposed transaction, Cepton will operate as a privately held indirect subsidiary of Koito in the U.S.,...
CommScope Announces Preliminary Second Quarter 2024 Results
Preliminary Second Quarter Results Consolidated net sales of $1.39 billion Core net sales of $1.05 billion* GAAP income from continuing...
Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology
– Adds Commercial Product Jornay PM®, Establishing Collegium’s Presence in Neurology (ADHD) –– H1’24 Jornay PM Prescriptions Grew 32% Year-over-Year...
Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer’s Association International Conference® 2024 (AAIC®)
--INVOKE-2 is the first global Phase 2 trial evaluating the safety and efficacy of a TREM2 agonist, AL002, in slowing...
Lipella Pharmaceuticals Initiates Phase 2a Trial for LP-310 in Oral Lichen Planus, Enrolls First Patients
PITTSBURGH, July 29, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company...
Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC)
– Featured Research Session oral presentation highlights findings that show Lomecel-B™ improved cognitive function, quality of life, and brain volume...
LuxUrban Hotels Announces Pricing of Public Offering of Securities
MIAMI, July 26, 2024 (GLOBE NEWSWIRE) -- LuxUrban Hotels Inc. (“LuxUrban” or the “Company”) (Nasdaq: LUXH), which secures long-term operating...
Cognition Therapeutics to Host Investor Webcast to Discuss Results from Proof-of-Concept Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease at 8:30am ET on Monday July 29, 2024
PURCHASE, N.Y., July 26, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage...
Rail Vision Receives Nasdaq Notification Regarding Minimum Bid Requirements
Ra’anana, Israel, July 26, 2024 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (the “Company”) (Nasdaq: RVSN), a technology company at the...
LuxUrban Hotels Launches Proposed Public Offering of Securities
MIAMI, July 26, 2024 (GLOBE NEWSWIRE) -- LuxUrban Hotels Inc. (“LuxUrban” or the “Company”) (Nasdaq: LUXH), which secures long-term operating...